{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:25:16Z","timestamp":1789629916300,"version":"build-2803163510"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/bor.0000000000000218","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T11:21:01Z","timestamp":1441884061000},"page":"530-536","source":"Crossref","is-referenced-by-count":41,"title":["Update on macrophages and innate immunity in scleroderma"],"prefix":"10.1097","volume":"27","author":[{"given":"Jennifer J.","family":"Chia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa T.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis.","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/eci.11.40","article-title":"Novel insights on the role of the innate immune system in systemic sclerosis.","volume":"7","author":"York","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-011-0215-5","article-title":"Dendritic cells: novel players in fibrosis and scleroderma.","volume":"14","author":"Lu","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/CS20130367","article-title":"Innate immunity in systemic sclerosis pathogenesis.","volume":"126","author":"OReilly","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/exd.12727","article-title":"Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma.","volume":"24","author":"Manetti","year":"2015","journal-title":"Exp Dermatol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/imr.12020","article-title":"Cellular immune reactions in the lung.","volume":"251","author":"Hasenberg","year":"2013","journal-title":"Immunol Rev"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ni.2680","article-title":"The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells.","volume":"14","author":"Heath","year":"2013","journal-title":"Nat Immunol"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation.","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3683","article-title":"The origins and functions of dendritic cells and macrophages in the skin.","volume":"14","author":"Malissen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R10-3-20210128","first-page":"110","article-title":"Interferons and scleroderma-a new clue to understanding the pathogenesis of scleroderma Immunol L","volume":"118","author":"Coelho","year":"2008","journal-title":"ett"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-012-0297-8","article-title":"The immune pathogenesis of scleroderma: context is everything.","volume":"15","author":"Greenblatt","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","article-title":"Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.","volume":"17","author":"Bhattacharyya","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis.","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40169-015-0047-4","article-title":"The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases.","volume":"4","author":"Wermuth","year":"2015","journal-title":"Clin Transl Med"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease.","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.immuni.2013.10.004","article-title":"Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin.","volume":"39","author":"Tamoutounour","year":"2013","journal-title":"Immunity"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis.","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages.","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","article-title":"C-Myb() erythro-myeloid progenitor- derived fetal monocytes give rise to adult tissue-resident macrophages.","volume":"42","author":"Hoeffel","year":"2015","journal-title":"Immunity"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors.","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: Nomenclature and Experimental Guidelines.","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocytemacrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1006\/cyto.2000.0720","article-title":"Human monocytes express CD163, which is upregulated by IL-10 and identical to p155.","volume":"12","author":"Sulahian","year":"2000","journal-title":"Cytokine"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor -regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","article-title":"Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.","volume":"73","author":"Mathes","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.","volume":"21","author":"Ohl","year":"2004","journal-title":"Immunity"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1073\/pnas.0511043103","article-title":"Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.","volume":"103","author":"Trogan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance.","volume":"8","author":"Forster","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2010.05.017","article-title":"Lymphoid chemokines in the CNS.","volume":"224","author":"Lalor","year":"2010","journal-title":"J Neuroimmunol"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.30232","article-title":"Characterization of CCL19 and CCL21 in rheumatoid arthritis.","volume":"63","author":"Pickens","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S","article-title":"Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s002960050098","article-title":"Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis.","volume":"19","author":"Distler","year":"1999","journal-title":"Rheumatol Int"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0923-1811(00)00169-9","article-title":"Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.","volume":"26","author":"Yamamoto","year":"2001","journal-title":"J Dermatol Sci"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO;2-T","article-title":"Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.","volume":"44","author":"Galindo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/jid.2010.200","article-title":"Poly(I:C) drives type I IFN- and TGF-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.","volume":"130","author":"Farina","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.30318","article-title":"Interferon and alternative activation of monocytemacrophages in systemic sclerosis-associated pulmonary arterial hypertension.","volume":"63","author":"Christmann","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1600-0625.2008.00828.x","article-title":"Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.","volume":"18","author":"Higashi-Kuwata","year":"2009","journal-title":"Exp Dermatol"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.38275","article-title":"Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1096\/fj.11-186098","article-title":"Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-beta production and epithelial to mesenchymal transition.","volume":"26","author":"Schneider","year":"2011","journal-title":"FASEB J"},{"key":"R41-3-20210128","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.21894","article-title":"Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts.","volume":"54","author":"Gardner","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R42-3-20210128","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type- specific gene expression patterns in scleroderma skin.","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/exd.12730","article-title":"Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma.","volume":"24","author":"Kato","year":"2015","journal-title":"Exp Dermatol"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation.","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3.","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J Immunol"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jmb.2013.12.004","article-title":"Galectin-3 interactions with glycosphingolipids.","volume":"426","author":"Collins","year":"2014","journal-title":"J Mol Biol"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jcb.240510316","article-title":"High mannose type N-linked oligosaccharides on endothelial cells may influence beta 2 integrin mediated neutrophil adherence in vitro.","volume":"51","author":"Sriramarao","year":"1993","journal-title":"J Cell Biochem"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9440(10)64882-1","article-title":"Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation.","volume":"160","author":"McNally","year":"2002","journal-title":"Am J Pathol"},{"key":"R49-3-20210128","first-page":"6837","article-title":"Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration.","volume":"62","author":"Guo","year":"2002","journal-title":"Cancer Res"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jcb.21071","article-title":"Increase in beta1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin beta1 stability in human hepatocellular carcinoma cell line SMMC-7721.","volume":"100","author":"Wang","year":"2007","journal-title":"J Cell Biochem"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1073\/pnas.1308887110","article-title":"Modulation of macrophage phenotype by cell shape.","volume":"110","author":"McWhorter","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R52-3-20210128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R53-3-20210128","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1074\/jbc.M010133200","article-title":"Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway.","volume":"276","author":"Czuwara-Ladykowska","year":"2001","journal-title":"J Biol Chem"},{"key":"R54-3-20210128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down- regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.","volume":"163","author":"Kubo","year":"2003","journal-title":"Am J Pathol"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R56-3-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","article-title":"Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.","volume":"29","author":"Asano","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R57-3-20210128","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"key":"R58-3-20210128","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"key":"R59-3-20210128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.1219179","article-title":"A lineage of myeloid cells independent of Myb and hematopoietic stem cells.","volume":"336","author":"Schulz","year":"2012","journal-title":"Science"},{"key":"R60-3-20210128","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2013.05.033","article-title":"Dendritic cells in liver injury and fibrosis: shortcomings and promises.","volume":"59","author":"Lukacs-Kornek","year":"2013","journal-title":"J Hepatol"},{"key":"R61-3-20210128","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis.","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"R62-3-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ.","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R63-3-20210128","doi-asserted-by":"crossref","first-page":"e1004372","DOI":"10.1371\/journal.ppat.1004372","article-title":"Incomplete deletion of IL-4R by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis.","volume":"10","author":"Vannella","year":"2014","journal-title":"PLoS Pathog"},{"key":"R64-3-20210128","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajpath.2014.11.027","article-title":"Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis.","volume":"185","author":"Falkenham","year":"2015","journal-title":"Am J Pathol"},{"key":"R65-3-20210128","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood-2008-07-170787","article-title":"CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.","volume":"113","author":"Landsman","year":"2009","journal-title":"Blood"},{"key":"R66-3-20210128","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4049\/jimmunol.1004164","article-title":"Cutting edge: protective effect of CX3CR1 dendritic cells in a vaccinia virus pulmonary infection model.","volume":"188","author":"Bonduelle","year":"2012","journal-title":"J Immunol"},{"key":"R67-3-20210128","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"R68-3-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"R69-3-20210128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.","volume":"197","author":"Lasagni","year":"2003","journal-title":"J Exp Med"},{"key":"R70-3-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions.","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"R71-3-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/FJC.0b013e31813c6cc3","article-title":"Mechanisms of ET-1-induced endothelial dysfunction.","volume":"50","author":"Iglarz","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 5","key":"R72-3-20210128","doi-asserted-by":"crossref","first-page":"v25","DOI":"10.1093\/rheumatology\/ken283","article-title":"Endothelin and scleroderma lung disease.","volume":"47","author":"Silver","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R73-3-20210128","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jcp.24337","article-title":"Interferon- promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) 2.","volume":"228","author":"Chrobak","year":"2013","journal-title":"J Cell Physiol"},{"key":"R74-3-20210128","doi-asserted-by":"crossref","first-page":"e2657","DOI":"10.1371\/journal.pone.0002657","article-title":"The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.","volume":"3","author":"Aidoudi","year":"2008","journal-title":"PLoS One"},{"key":"R75-3-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2012.96","article-title":"The pathogenesis, diagnosis and treatment of Raynaud phenomenon.","volume":"8","author":"Herrick","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R76-3-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"R77-3-20210128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity.","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"R78-3-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/exd.12603","article-title":"CpGB DNA activates dermal macrophages and specifically recruits inflammatory monocytes into the skin.","volume":"24","author":"Mathes","year":"2015","journal-title":"Exp Dermatol"},{"key":"R79-3-20210128","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1073\/pnas.1207314109","article-title":"Identification of the platelet-derived chemokine CXCL4PF-4 as a broad-spectrum HIV-1 inhibitor.","volume":"109","author":"Auerbach","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R80-3-20210128","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar4598","article-title":"Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis.","volume":"16","author":"Stifano","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R81-3-20210128","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9","article-title":"The complement receptor 3, CR3(CD11bCD18), on T lymphocytes: activation-dependent up-regulation and regulatory function.","volume":"31","author":"Wagner","year":"2001","journal-title":"Eur J Immunol"},{"key":"R82-3-20210128","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4.","volume":"341","author":"Kayagaki","year":"2013","journal-title":"Science"},{"key":"R83-3-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor- responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am J Pathol"},{"key":"R84-3-20210128","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","article-title":"Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.","volume":"67","author":"Takahashi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R85-3-20210128","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates Toll-like receptor 4.","volume":"276","author":"Okamura","year":"2001","journal-title":"J Biol Chem"},{"key":"R86-3-20210128","doi-asserted-by":"crossref","first-page":"232ra50","DOI":"10.1126\/scitranslmed.3008264","article-title":"FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.","volume":"6","author":"Bhattacharyya","year":"2014","journal-title":"Sci Transl Med"},{"key":"R87-3-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/10799890902845690","article-title":"Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-Akt pathway in fibroblasts during acute lung injury.","volume":"29","author":"He","year":"2009","journal-title":"J Recept Signal Transduct Res"},{"key":"R88-3-20210128","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/rheumatology\/ker021","article-title":"Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.","volume":"50","author":"Geurts","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R89-3-20210128","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1167\/iovs.10-5459","article-title":"Lipopolysaccharide regulation of toll-like receptor-4 and matrix metalloprotease-9 in human primary corneal fibroblasts.","volume":"52","author":"Wong","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R90-3-20210128","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/jcp.22454","article-title":"Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring.","volume":"226","author":"Wang","year":"2011","journal-title":"J Cell Physiol"},{"key":"R91-3-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor- associated kinase 4 and nuclear factor-B.","volume":"143","author":"OReilly","year":"2014","journal-title":"Immunology"},{"key":"R92-3-20210128","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1874312901206010072","article-title":"New insights into the mechanisms of innate immune receptor signalling in fibrosis.","volume":"6","author":"Lafyatis","year":"2012","journal-title":"Open Rheumatol J"},{"key":"R93-3-20210128","first-page":"1","article-title":"Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29).","volume":"9","author":"Dantas","year":"2015","journal-title":"Autoimmunity"},{"key":"R94-3-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family.","volume":"30","author":"Donnelly","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"R95-3-20210128","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/emi.2014.51","article-title":"The impact of the interferon- lambda family on the innate and adaptive immune response to viral infections.","volume":"3","author":"Egli","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"R96-3-20210128","doi-asserted-by":"crossref","first-page":"e105008","DOI":"10.1371\/journal.pone.0105008","article-title":"High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.","volume":"9","author":"Lonati","year":"2014","journal-title":"PLoS One"},{"key":"R97-3-20210128","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ni.2156","article-title":"IL-17C regulates the innate immune function of epithelial cells in an autocrine manner.","volume":"12","author":"Ramirez-Carrozzi","year":"2011","journal-title":"Nat Immunol"},{"key":"R98-3-20210128","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation.","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg Microbes Infect"},{"key":"R99-3-20210128","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis.","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R100-3-20210128","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.","volume":"188","author":"Nakashima","year":"2012","journal-title":"J Immunol"},{"key":"R101-3-20210128","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A cells are increased in systemic sclerosis skin and their number is inversely correlated to the extent of skin involvement.","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R102-3-20210128","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis.","volume":"187","author":"Lin","year":"2011","journal-title":"J Immunol"},{"key":"R103-3-20210128","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/jid.2014.142","article-title":"Rethinking the potential roles of mast cells in skin wound healing and bleomycin-induced skin fibrosis.","volume":"134","author":"Galli","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R104-3-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-1568-2_7","article-title":"Mast cells in human health and disease.","volume":"1220","author":"DeBruin","year":"2015","journal-title":"Methods Mol Biol"},{"key":"R105-3-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/dna.2013.2005","article-title":"Mast cells: a pivotal role in pulmonary fibrosis.","volume":"32","author":"Veerappan","year":"2013","journal-title":"DNA Cell Biol"},{"key":"R106-3-20210128","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4049\/jimmunol.1300875","article-title":"Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymasemast cell protease 4-dependent mechanism.","volume":"192","author":"Reber","year":"2014","journal-title":"J Immunol"},{"key":"R107-3-20210128","first-page":"2628","article-title":"Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-WW(V) mice.","volume":"26","author":"Yamamoto","year":"1999","journal-title":"J Rheumatol"},{"key":"R108-3-20210128","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/jid.2014.12","article-title":"Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin- induced fibrosis.","volume":"134","author":"Willenborg","year":"2014","journal-title":"J Invest Dermatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:34:12Z","timestamp":1620948852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201511000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000218","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}